ASH 2014 | ASH 2014: Treating mantle cell lymphoma (Part 3)

Andre Goy and John Gribben

Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Andre Goy (John Theurer Cancer Center, Hackensack, NJ) at the 2014 American Society of Hematology (ASH) Annual Meeting about maintenance therapy with rituximab for the management of patients with mantle cell lymphoma.

Share this video  
Similar topics